WebThe E. coli PNP Therapeutic System has been shown to be effective against these refractory tumors precisely because fluoroadenine, the active metabolite in the Company's first product configuration, attacks and kills both the dividing and non-dividing cells which, unlike most other anti-tumor agents, destroys the non-proliferating component of … WebPNP Therapeutics®, Inc., is an early-stage, biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer. The technology is currently in Phase I clinical trials.
James Fuqua - President and Member of the Board of …
WebGedeptin - A Novel, Patented Immunotherapy for Solid Tumors. In late September 2024, GeoVax hosted a conference call to discuss the acquisition of Gedeptin from PNP Therapeutics. On the call, Dr. Eric Sorscher, MD, Professor at Emory University, School of Medicine and medical founder of PNP Therapeutics, outlined the key aspects of the … WebAug 17, 2015 · PNP Therapeutics, Inc. Jun 2013 - Present9 years 10 months Birmingham, Alabama PNP Therapeutics®, Inc. is an early-stage, … hotpoint hic 3c33 cw
PNP Therapeutics Company Profile: Valuation & Investors
WebAug 17, 2024 · See PNP Therapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on PNP Therapeutics's post-money valuation and revenue. WebJun 16, 2015 · PNP Therapeutics is the exclusive licensee of a comprehensive collection of patents that broadly and specifically cover the Company's technology. These patents are owned jointly by the UAB... WebNov 21, 2013 · PNP Therapeutics, Inc. — a company based on a gene-therapy technology developed by scientists at Southern Research Institute and the University of Alabama at … lindy\u0027s tucson